Vivos Therapeutics, Inc. VVOS Q1 2026 Annual earnings
Reported May 20, 2026 · After market close
Revenue$5.1MBeat by $792.3K
EPS-$0.52Miss by $0.07
Revenue estimate$4.3M
EPS estimate-$0.45
Next report
Aug 18, 2026 (In 2 weeks)Revenue estimate$5.6M
EPS estimate-$0.42
Versus estimates
Revenue
Diluted EPS
Ask the moment Vivos Therapeutics, Inc. reports.
Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.
Connect your AI
Claude
Questions, answered.
- When did Vivos Therapeutics, Inc. report Q1 2026 earnings?
- Vivos Therapeutics, Inc. (VVOS) reported Q1 2026 earnings on May 20, 2026 after market close.
- What were Vivos Therapeutics, Inc.'s Q1 2026 revenue and EPS?
- Vivos Therapeutics, Inc. reported revenue of $5.1M and eps of $-0.52 for Q1 2026.
- Did Vivos Therapeutics, Inc. beat estimates in Q1 2026?
- Revenue beat the consensus estimate of $4.3M by $792.3K. EPS missed the consensus estimate of $-0.45 by $0.07.
- How did Vivos Therapeutics, Inc.'s Q1 2026 results compare year-over-year?
- Compared to the same quarter a year prior, revenue grew 70.5% from $3.0M a year earlier and eps declined 15.6% from $-0.45.
- Where can I find Vivos Therapeutics, Inc.'s Q1 2026 SEC filings?
- You can read the 10-K periodic report (0001493152-26-016854) directly on SEC EDGAR. The filing index links above go to sec.gov.